Pathogen Surveillance for Acute Infectious Conjunctivitis
Importance: Acute infectious conjunctivitis is a common ocular condition with major public health consequences.
Objective: To assess regional variations and microbial etiologies of acute infectious conjunctivitis to guide treatment.
Design, Setting, and Participants: In this cross-sectional study, patients with presumed acute infectious conjunctivitis were enrolled in the study at 5 sites (Honolulu, Hawaii; Los Angeles, San Francisco, and San Diego, California; and Petah-Tikva, Israel) from March 2021 to March 2023. Patients with allergic or toxic conjunctivitis were excluded.
Main Outcomes and Measures: Pathogens were identified by unbiased RNA deep sequencing.
Results: In all, 52 patients (mean [range] age, 48 [7-80] years; 31 females [60%]) were enrolled at 5 sites (6 patients from Honolulu, 9 from San Diego, 11 from Los Angeles, 13 from San Francisco, and 13 from Petah-Tikva). RNA deep sequencing detected human adenovirus species D in one-quarter of patients (13 of 52). A wide range of pathogens, including human coronavirus 229E, SARS-CoV-2, and herpes simplex virus type 1, was also identified, as well as several bacteria and fungi. Moreover, 62% (32 of 52) of patients presented with purulent discharge, while only 8% (4 of 52) of patients had confirmed bacterial pathogens.
Conclusion and Relevance: In this cross-sectional study, pathogens associated with acute infectious conjunctivitis varied between all 5 sites in the US and Israel. Purulent discharge was a common presenting sign in this study, with a low specificity for bacteria-associated conjunctivitis, suggesting that further diagnostic workup may be necessary to inform antibiotic stewardship. Additional research on cost-effectiveness of using RNA deep sequencing is needed to ascertain whether it is better to monitor patients clinically until resolution of disease.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:141 |
---|---|
Enthalten in: |
JAMA ophthalmology - 141(2023), 12 vom: 01. Dez., Seite 1140-1144 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tsui, Edmund [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 27.12.2023 Date Revised 27.12.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1001/jamaophthalmol.2023.4785 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364089601 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM364089601 | ||
003 | DE-627 | ||
005 | 20231229124152.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1001/jamaophthalmol.2023.4785 |2 doi | |
028 | 5 | 2 | |a pubmed24n1241.xml |
035 | |a (DE-627)NLM364089601 | ||
035 | |a (NLM)37917077 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tsui, Edmund |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pathogen Surveillance for Acute Infectious Conjunctivitis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.12.2023 | ||
500 | |a Date Revised 27.12.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Importance: Acute infectious conjunctivitis is a common ocular condition with major public health consequences | ||
520 | |a Objective: To assess regional variations and microbial etiologies of acute infectious conjunctivitis to guide treatment | ||
520 | |a Design, Setting, and Participants: In this cross-sectional study, patients with presumed acute infectious conjunctivitis were enrolled in the study at 5 sites (Honolulu, Hawaii; Los Angeles, San Francisco, and San Diego, California; and Petah-Tikva, Israel) from March 2021 to March 2023. Patients with allergic or toxic conjunctivitis were excluded | ||
520 | |a Main Outcomes and Measures: Pathogens were identified by unbiased RNA deep sequencing | ||
520 | |a Results: In all, 52 patients (mean [range] age, 48 [7-80] years; 31 females [60%]) were enrolled at 5 sites (6 patients from Honolulu, 9 from San Diego, 11 from Los Angeles, 13 from San Francisco, and 13 from Petah-Tikva). RNA deep sequencing detected human adenovirus species D in one-quarter of patients (13 of 52). A wide range of pathogens, including human coronavirus 229E, SARS-CoV-2, and herpes simplex virus type 1, was also identified, as well as several bacteria and fungi. Moreover, 62% (32 of 52) of patients presented with purulent discharge, while only 8% (4 of 52) of patients had confirmed bacterial pathogens | ||
520 | |a Conclusion and Relevance: In this cross-sectional study, pathogens associated with acute infectious conjunctivitis varied between all 5 sites in the US and Israel. Purulent discharge was a common presenting sign in this study, with a low specificity for bacteria-associated conjunctivitis, suggesting that further diagnostic workup may be necessary to inform antibiotic stewardship. Additional research on cost-effectiveness of using RNA deep sequencing is needed to ascertain whether it is better to monitor patients clinically until resolution of disease | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Sella, Ruti |e verfasserin |4 aut | |
700 | 1 | |a Tham, Vivien |e verfasserin |4 aut | |
700 | 1 | |a Kong, Alan W |e verfasserin |4 aut | |
700 | 1 | |a McClean, Esmeralda |e verfasserin |4 aut | |
700 | 1 | |a Goren, Lee |e verfasserin |4 aut | |
700 | 1 | |a Bahar, Irit |e verfasserin |4 aut | |
700 | 1 | |a Cherian, Nina |e verfasserin |4 aut | |
700 | 1 | |a Ramirez, Joana |e verfasserin |4 aut | |
700 | 1 | |a Hughes, Reginald E |c Jr |e verfasserin |4 aut | |
700 | 1 | |a Privratsky, Joseph K |e verfasserin |4 aut | |
700 | 1 | |a Onclinx, Tania |e verfasserin |4 aut | |
700 | 1 | |a Feit-Leichman, Rachel |e verfasserin |4 aut | |
700 | 1 | |a Cheng, Angel |e verfasserin |4 aut | |
700 | 1 | |a Molina, Iliana |e verfasserin |4 aut | |
700 | 1 | |a Kim, Phillip |e verfasserin |4 aut | |
700 | 1 | |a Yu, Carol |e verfasserin |4 aut | |
700 | 1 | |a Ruder, Kevin |e verfasserin |4 aut | |
700 | 1 | |a Tan, Alexander |e verfasserin |4 aut | |
700 | 1 | |a Chen, Cindi |e verfasserin |4 aut | |
700 | 1 | |a Liu, YuHeng |e verfasserin |4 aut | |
700 | 1 | |a Abraham, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Hinterwirth, Armin |e verfasserin |4 aut | |
700 | 1 | |a Zhong, Lina |e verfasserin |4 aut | |
700 | 1 | |a Porco, Travis C |e verfasserin |4 aut | |
700 | 1 | |a Lietman, Thomas M |e verfasserin |4 aut | |
700 | 1 | |a Seitzman, Gerami D |e verfasserin |4 aut | |
700 | 1 | |a Doan, Thuy |e verfasserin |4 aut | |
700 | 0 | |a SCORPIO Study Group |e verfasserin |4 aut | |
700 | 1 | |a Prajna, Lalitha |e investigator |4 oth | |
700 | 1 | |a Prajna, N Venkatesh |e investigator |4 oth | |
700 | 1 | |a Gunasekaran, Ramesh |e investigator |4 oth | |
700 | 1 | |a Sharma, Sankalp Singh |e investigator |4 oth | |
700 | 1 | |a Teja, Vishnu |e investigator |4 oth | |
700 | 1 | |a Chaudhary, Meenu |e investigator |4 oth | |
700 | 1 | |a Sitaula, Sanjeeta |e investigator |4 oth | |
700 | 1 | |a Sié, Ali |e investigator |4 oth | |
700 | 1 | |a Coulibaly, Boubacar |e investigator |4 oth | |
700 | 1 | |a Bountogo, Mamadou |e investigator |4 oth | |
700 | 1 | |a Somkijrungroj, Thanapong |e investigator |4 oth | |
700 | 1 | |a Satitpitakul, Vannarut |e investigator |4 oth | |
700 | 1 | |a Tran, Huy |e investigator |4 oth | |
700 | 1 | |a Mai, Linh Hoàng |e investigator |4 oth | |
700 | 1 | |a Xuân, Thảo Hạ |e investigator |4 oth | |
700 | 1 | |a Tran, Yen |e investigator |4 oth | |
700 | 1 | |a Urzua, Cristhian A |e investigator |4 oth | |
700 | 1 | |a Vega, Fabian |e investigator |4 oth | |
700 | 1 | |a Salgado, Felipe |e investigator |4 oth | |
700 | 1 | |a Cuitino, Loreto |e investigator |4 oth | |
700 | 1 | |a Pérez, Fernando Pérez |e investigator |4 oth | |
700 | 1 | |a Macías Martínez, Jaime |e investigator |4 oth | |
700 | 1 | |a Lansingh, Van Charles |e investigator |4 oth | |
700 | 1 | |a Thanapaisal, Sukhumal |e investigator |4 oth | |
700 | 1 | |a Laovirojjanakul, Wipada |e investigator |4 oth | |
700 | 1 | |a McKie, George |e investigator |4 oth | |
700 | 1 | |a Chavez, Kenia |e investigator |4 oth | |
700 | 1 | |a Redd, Travis |e investigator |4 oth | |
700 | 1 | |a Chamberlain, Winston |e investigator |4 oth | |
700 | 1 | |a Sansanayudh, Wiwan |e investigator |4 oth | |
700 | 1 | |a Yakoura, Abba Kaka Hajia |e investigator |4 oth | |
700 | 1 | |a Amza, Abdou |e investigator |4 oth | |
700 | 1 | |a Youssoufou Souley, Abdoul Salam |e investigator |4 oth | |
700 | 1 | |a Nouhou Diori, Adam |e investigator |4 oth | |
700 | 1 | |a Nassirou, Beido |e investigator |4 oth | |
700 | 1 | |a Kadri, Boubacar |e investigator |4 oth | |
700 | 1 | |a Mariama, Boubacar |e investigator |4 oth | |
700 | 1 | |a Ibrahim, Cissé Mamadou |e investigator |4 oth | |
700 | 1 | |a Roufaye, Lamine Aboubacar |e investigator |4 oth | |
700 | 1 | |a Boulhassane, Ramatou |e investigator |4 oth | |
700 | 1 | |a Ali, Saley |e investigator |4 oth | |
700 | 1 | |a Abdou, Zakou |e investigator |4 oth | |
700 | 1 | |a Kelliher, Clare |e investigator |4 oth | |
700 | 1 | |a Green, Laura |e investigator |4 oth | |
700 | 1 | |a Ong, Hon Shing |e investigator |4 oth | |
700 | 1 | |a Mehta, Jod |e investigator |4 oth | |
700 | 1 | |a Liu, Yu-Chi |e investigator |4 oth | |
700 | 1 | |a Hwang, De-Kuang |e investigator |4 oth | |
700 | 1 | |a Fan, Nai-Wen |e investigator |4 oth | |
700 | 1 | |a Chiong, Hong Sheng |e investigator |4 oth | |
700 | 1 | |a Lacorzana, Javier |e investigator |4 oth | |
700 | 1 | |a Cabrera-Aguas, Maria |e investigator |4 oth | |
700 | 1 | |a Watson, Stephanie |e investigator |4 oth | |
700 | 1 | |a Lebas, Elodie |e investigator |4 oth | |
700 | 1 | |a Colby, Emily |e investigator |4 oth | |
700 | 1 | |a McLeod, Stephen |e investigator |4 oth | |
700 | 1 | |a Kanai, Kuniyoshi |e investigator |4 oth | |
700 | 1 | |a Whiteside, Meredith |e investigator |4 oth | |
700 | 1 | |a Yeh, Steven |e investigator |4 oth | |
700 | 1 | |a Fashina, Tolulope |e investigator |4 oth | |
700 | 1 | |a Chodosh, James |e investigator |4 oth | |
700 | 1 | |a Tarkap, Bridgit |e investigator |4 oth | |
700 | 1 | |a Garap, Jambi N |e investigator |4 oth | |
700 | 1 | |a Mangot, Magdalene |e investigator |4 oth | |
700 | 1 | |a Amel, Edwin |e investigator |4 oth | |
700 | 1 | |a Taleo, Fasihah |e investigator |4 oth | |
700 | 1 | |a Kasso, Johnson |e investigator |4 oth | |
700 | 1 | |a Willie, Kalbule |e investigator |4 oth | |
700 | 1 | |a Nanu, Madopule |e investigator |4 oth | |
700 | 1 | |a Rymill, Prudence |e investigator |4 oth | |
700 | 1 | |a Solomon, Anthony W |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t JAMA ophthalmology |d 2013 |g 141(2023), 12 vom: 01. Dez., Seite 1140-1144 |w (DE-627)NLM220905169 |x 2168-6173 |7 nnns |
773 | 1 | 8 | |g volume:141 |g year:2023 |g number:12 |g day:01 |g month:12 |g pages:1140-1144 |
856 | 4 | 0 | |u http://dx.doi.org/10.1001/jamaophthalmol.2023.4785 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 141 |j 2023 |e 12 |b 01 |c 12 |h 1140-1144 |